Welcome Stockaholics!

We are a new and fast growing financial forum! Sign up for free and let's talk stocks!

  1. Do you want to help develop this community? We are looking for contributions from investors and traders like you! What stocks do you follow? What is hot right now? Sign up and get in on the ground floor of the newest, fastest growing financial forum!
    Dismiss Notice
  2. You will notice a live chat widget on the right. Click in to join us and lets hear about how you nailed that last UWTI trade!
    Dismiss Notice

OCUL - Ocular Therapeutix

Discussion in 'Stock Message Boards NYSE, NASDAQ, AMEX' started by StockJock-e, Aug 5, 2016.

  1. StockJock-e

    StockJock-e Brew Master
    Staff Member

    Joined:
    Apr 3, 2016
    Messages:
    5,429
    Likes Received:
    1,281
    Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies for diseases and conditions of the eye using its proprietary hydrogel platform technology in the United States. It markets ReSure Sealant, a hydrogel-based ophthalmic wound sealant to seal corneal incisions following cataract surgery. The company's lead product include DEXTENZA, which is in Phase III clinical trial for the treatment of post-surgical ocular inflammation and pain during cataract surgery, as well as for the treatment of allergic conjunctivitis; and in Phase II clinical trial for the treatment of inflammatory dry eye disease. It is also developing OTX-TP, which has completed Phase IIb clinical trial for glaucoma and ocular hypertension. In addition, the company has a pipeline of earlier stage punctum plug product candidates, including OTX-MP, which has completed a Phase I clinical trial evaluating safety and pharmacokinetics in patients during cataract surgery; and evaluates sustained-release injectable anti-VEGF drug depots for back-of-the-eye diseases. Ocular Therapeutix, Inc. was founded in 2006 and is headquartered in Bedford, Massachusetts.

    [​IMG]
     
  2. StockJock-e

    StockJock-e Brew Master
    Staff Member

    Joined:
    Apr 3, 2016
    Messages:
    5,429
    Likes Received:
    1,281
    Ocular Therapeutix (OCL) Stock Soars, FDA: Corrective Actions Address Concerns

    NEW YORK (TheStreet) -- Shares of Ocular Therapeutix (OCUL) were rising 31.19% to $5.51 on heavy trading volume early Thursday afternoon after the Food and Drug Administration released a note saying the company's corrective actions on its new drug application for Dextenza have addressed the agency's concern.

    Over 4.18 million shares of the Bedford, MA-based biopharmaceutical company have traded so far today, well above its 30-day daily average of 504,000 shares.
     
  3. StockJock-e

    StockJock-e Brew Master
    Staff Member

    Joined:
    Apr 3, 2016
    Messages:
    5,429
    Likes Received:
    1,281
    Pretty good move here into the close, it managed to hold a lot of the gains!
     
  4. Tiptopptrader

    Tiptopptrader Well-Known Member

    Joined:
    Mar 31, 2016
    Messages:
    5,036
    Likes Received:
    1,143
  5. StockJock-e

    StockJock-e Brew Master
    Staff Member

    Joined:
    Apr 3, 2016
    Messages:
    5,429
    Likes Received:
    1,281
    Big gapper!

    That $8 resistance is holding it down for now.
     
  6. LloydWCoutee

    LloydWCoutee Active Member

    Joined:
    May 4, 2016
    Messages:
    725
    Likes Received:
    57
    MM could be looking for a nice place to play today. The rest of the market is not that place
     
  7. StockJock-e

    StockJock-e Brew Master
    Staff Member

    Joined:
    Apr 3, 2016
    Messages:
    5,429
    Likes Received:
    1,281
    Need to see a breakout over $8 here
     
  8. T0rm3nted

    T0rm3nted Moderator
    Staff Member

    Joined:
    Apr 2, 2016
    Messages:
    5,521
    Likes Received:
    919
    Analyst Upgrade/Downgrade Update

    Brokerage firm:
    RBC Capital Mkts
    Change: Coverage Reiterated/Price Target Changed
    Previous Rating: N/A
    Current Rating: Outperform
    Previous Price Target: $30
    Current Price Target: $32
     
  9. Tiptopptrader

    Tiptopptrader Well-Known Member

    Joined:
    Mar 31, 2016
    Messages:
    5,036
    Likes Received:
    1,143
    Moving on that upgrade

    upload_2016-11-16_8-13-16.png
     
  10. StockJock-e

    StockJock-e Brew Master
    Staff Member

    Joined:
    Apr 3, 2016
    Messages:
    5,429
    Likes Received:
    1,281
    Gap fill levels coming up!

    [​IMG]
     
    T0rm3nted likes this.
  11. Tiptopptrader

    Tiptopptrader Well-Known Member

    Joined:
    Mar 31, 2016
    Messages:
    5,036
    Likes Received:
    1,143
    Giving back today on strong volume

    upload_2016-11-21_8-40-56.png
     
  12. StockJock-e

    StockJock-e Brew Master
    Staff Member

    Joined:
    Apr 3, 2016
    Messages:
    5,429
    Likes Received:
    1,281
    lets see if $9 holds, still looking good after that big run!
     
  13. StockJock-e

    StockJock-e Brew Master
    Staff Member

    Joined:
    Apr 3, 2016
    Messages:
    5,429
    Likes Received:
    1,281
    The resistance levels from my last chart held perfectly, now if $9 holds, remain bullish in the short term.

    [​IMG]
     
  14. StockJock-e

    StockJock-e Brew Master
    Staff Member

    Joined:
    Apr 3, 2016
    Messages:
    5,429
    Likes Received:
    1,281
    Continuation of the sell off from the $12 resistance
     
  15. Tiptopptrader

    Tiptopptrader Well-Known Member

    Joined:
    Mar 31, 2016
    Messages:
    5,036
    Likes Received:
    1,143
  16. StockJock-e

    StockJock-e Brew Master
    Staff Member

    Joined:
    Apr 3, 2016
    Messages:
    5,429
    Likes Received:
    1,281
    $6 support was solid, moving here
     
  17. StockJock-e

    StockJock-e Brew Master
    Staff Member

    Joined:
    Apr 3, 2016
    Messages:
    5,429
    Likes Received:
    1,281
    Ocular TherapeutixTM to Present at Three Upcoming Investor Conferences

    EDFORD, Mass.--(BUSINESS WIRE)--


    • 2017 BIO CEO & Investor Conference
      Monday, February 13, 2017 at 8:30 a.m. Eastern Time
      The Waldorf Astoria New York, New York, NY
    • 2017 RBC Capital Markets Global Healthcare Conference
      Thursday, February 23, 2017 at 9:00 a.m. Eastern Time
      The New York Palace Hotel, New York, NY
    • 37th Annual Cowen and Company Healthcare Conference
      Monday, March 6, 2017 at 2:40 p.m. Eastern Time
      The Boston Marriott Copley Place, Boston, MA
     
  18. Gambit

    Gambit Active Member

    Joined:
    Oct 16, 2016
    Messages:
    705
    Likes Received:
    61
    $OCUL wow. missed all this. A lot of carnage around $9.75 from stop losses. Trying to figure out the next step!
     
  19. StockJock-e

    StockJock-e Brew Master
    Staff Member

    Joined:
    Apr 3, 2016
    Messages:
    5,429
    Likes Received:
    1,281
    Double down and revenge trade! :D
     
    Gambit likes this.
  20. StockJock-e

    StockJock-e Brew Master
    Staff Member

    Joined:
    Apr 3, 2016
    Messages:
    5,429
    Likes Received:
    1,281
    Breaking out over $9, looks like somebody may make their money back!
     

Share This Page